Neurogenic inflammation of the ocular surface

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 5, 2010, Pages 498-504

  Mantelli, Flavio ^a   Micera, Alessandra ^a,b   Sacchetti, Marta ^a   Bonini, Stefano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Allergic conjunctivitis; conjunctival provocation test; neurogenic inflammation; neuropeptide; ocular surface

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; EYE INFLAMMATION; HUMAN; IMMUNOSTIMULATION; INFLAMMATORY CELL; INNATE IMMUNITY; NEUROGENIC INFLAMMATION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CONJUNCTIVA; EYE DISEASES; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATION; NEUROGENIC INFLAMMATION; NEUROIMMUNOMODULATION; NEUROPEPTIDES; NOCICEPTORS; RECEPTORS, NEUROTRANSMITTER; SIGNAL TRANSDUCTION;

EID: 77956268428     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833e16cc     Document Type: Review

References (52)

1. Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 2002; 302:839-845.
2. Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967; 31:138-151.
3. Kulka M, Sheen CH,Tancowny BP, et al. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008; 123:398-410.
4. Fajac I, Braunstein G, Ickovic MR, et al. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995; 50:970-975.
5. Raap U, Wardlaw AJ. A new paradigm of eosinophil granulocytes: neuroim-mune interactions. Exp Dermatol 2008; 17:731-738.
6. Lacroix JS, Landis BN. Neurogenic inflammation of the upper airway mucosa. Rhinology 2008; 46:163-165.
7. Nockher WA, Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J Allergy Clin Immunol 2006; 117:67-71.
8. Butler CA, Heaney LG. Neurogenic inflammation and asthma. Inflamm Allergy Drug Targets 2007; 6:127-132.
9. Mosimann BL, White MV, Hohman RJ, et al. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993; 92 (1 Pt 1):95-104.
10. Wagner U, BredenbrokerD, Storm B, et al. Effects of VIP and related peptides on airway mucus secretion from isolated rat trachea. Peptides 1998; 19: 241-245.
11. Downing JE, Miyan JA. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today 2000; 21:281-289.
12. Micera A, Lambiase A, Bonini S. The role of neuromediators in ocular allergy. Curr Opin Allergy Clin Immunol 2008; 8:466-471.
13. Celander O, Folkow B. The correlation between the stimulation frequency and the dilator response evoked by 'antidromic' excitation of the thin afferent fibres in the dorsal roots. Acta Physiol Scand 1953; 29:371-376.
14. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997; 2:76-81.
15. Joachim RA, Handjiski B, Blois SM, et al. Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration: key role of intercellular adhesion molecule-1/leukocyte function-associated antigen interactions. Am J Pathol 2008; 173:1379-1388; Epub 2008 Oct 2.
16. Cevikbas F, Steinhoff A, Homey B, Steinhoff M. Neuroimmune interactions in allergic skin diseases. Curr Opin Allergy Clin Immunol 2007; 7:365-373.
17. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111:1683-1699.
18. Levite M, Chowers Y. Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner. Ann Oncol 2001; 12 (Suppl 2):S19-S25.
19. Andre E, Campi B, Materazzi S, et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 2008; 118:2574-2582.
20. Pfaar O, Raap U, Holz M, et al. Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly 2009; 139 (3-4):35-40.
21. Motterle L, Diebold Y, Enriquez de Salamanca A, et al. Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch Ophthalmol 2006; 124:462-468.
22. Beuerman RW, Stern ME. Neurogenic inflammation: a first line of defense for the ocular surface. Ocul Surf 2005; 3 (4 Suppl):S203-S206.
23. Kim JS, Okamoto K, Arima S, Rubin BK. Vasoactive intestinal peptide stimulates mucus secretion, but nitric oxide has no effect on mucus secretion in the ferret trachea. J Appl Physiol 2006; 101:486-491.
24. O'Connor TM, O'Connell J, O'Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol 2004; 201:167-180.
25. Bulut K, Felderbauer P, Deters S, et al. Sensory neuropeptides and epithelial cell restitution: the relevance of SP-and CGRP-stimulated mast cells. Int J Colorectal Dis 2008; 23:535-541.
26. Chu DQ, Cox HM, Costa SK, et al. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors. Br J Pharmacol 2003; 140:422-430.
27. Tam C, Brain SD. The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: a study using in vivo and in vitro assays in the mouse. J Mol Neurosci 2004; 22 (1-2):117-124.
28. Pozo D, Gonzalez-Rey E, Chorny A, et al. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders. Peptides 2007; 28:1833-1846.
29. Wheway J, Mackay CR, Newton RA, et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005; 202: 1527-1538.
30. Mantelli F, Lambiase A, Bonini S. A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases. Curr Opin Allergy Clin Immunol 2009; 9:471-476.
31. Fujishima H, Takeyama M, Takeuchi T, et al. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Allergy 1997; 27:372-378.
32. Lambiase A, Bonini S, Micera A, et al. Increased plasma levels of substance Pin vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 1997; 38:2161-2164.
33. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 2004; 56:249-290.
34. Abelson MB, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990; 108:84-88.
35. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol 2001; 169:429-435.
36. Befus AD, Mathison R, Davison J. Integration of neuro-endocrine immune responses in defense of mucosal surfaces. Am J Trop Med Hyg 1999; 60 (4 Suppl):26-34.
37. Luger TA. Neuromediators: a crucial component of the skin immune system. J Dermatol Sci 2002; 30:87-93.
38. Dartt DA. Regulation of lacrimal gland secretion by neurotransmitters and the EGF family of growth factors. Exp Eye Res 2001; 73:741-752.
39. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res 2002; 21:555-576.
40. Dartt DA, Kessler TL, Chung EH, Zieske JD. Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. Exp Eye Res 1996; 63:27-34.
41. Kovacs I, Ludany A, Koszegi T, et al. Substance P released from sensory nerve endings influences tear secretion and goblet cell function in the rat. Neuropeptides 2005; 39:395-402.
42. Batbayar B, Feher E, Nagy G, ZellesT. Changes of the nerve fibers innervating the minor salivary glands in Sjogren syndrome. Orv Hetil 2002; 143:1585-1588.
43. Batbayar B, Nagy G, Kovesi G, et al. Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjogren's syndrome. Arch Oral Biol 2004; 49:529-538.
44. Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren's syndrome. Exp Eye Res 2008; 86:879-885.
45. Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. Arch Ophthalmol 2009; 127:1468-1473.
46. Niissalo S, Hukkanen M, Imai S, et al. Neuropeptides in experimental and degenerative arthritis. Ann N Y Acad Sci 2002; 966:384-399.
47. Juarranz Y, Abad C, Martinez C, et al. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther 2005; 7:R1034-R1045.
48. Chen J, Vistica B, Wiggert B, et al. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice. Ocul Immunol Inflamm 2005; 13:13-17.
49. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5:75-92.
50. Seifert P, Spitznas M. Demonstration of nerve fibers in human accessory lacrimal glands. Graefes Arch Clin Exp Ophthalmol 1994; 232:107-114.
51. Erie JC, McLaren JW, Hodge DO, Bourne WM. Recovery of corneal subbasal nerve density after PRK and LASIK. Am J Ophthalmol 2005; 140:1059-1064.
52. Sitompul R, Sancoyo GS, Hutauruk JA, Gondhowiardjo TD. Sensitivity change in cornea and tear layer due to incision difference on cataract surgery with either manual small-incision cataract surgery or phacoemulsification. Cornea 2008; 27 (Suppl 1):S13-S18.